ClinVar Miner

Submissions for variant NM_007254.4(PNKP):c.668G>T (p.Gly223Val)

dbSNP: rs796052851
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000188432 SCV000242045 uncertain significance not provided 2013-05-03 criteria provided, single submitter clinical testing p.Gly223Val (GGG>GTG): c.668 G>T in exon 7 of the PNKP gene (NM_007254.2) The Gly223Val missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The amino acid substitution is conservative as both Glycine and Valine are uncharged, non-polar amino acid residues. Gly223Val alters a position that is not highly conserved in the DNA phosphatase domain of the PNKP protein. However, other missense mutations have not been reported at nearby codons. In addition, while one in-silico algorithm predicts Gly223Val is damaging to the structure/function of the protein, other algorithms predict it is not pathogenic. Therefore, based on the currently available information, it is unclear whether Gly223Val is is a disease-causing mutation or a rare benign variant. The variant is found in EPILEPSY panel(s).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.